+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A tranqlizer-anticholinergic preparation in functional gastrointestinal disorders: a double-blind evaluation



A tranqlizer-anticholinergic preparation in functional gastrointestinal disorders: a double-blind evaluation



California Medicine 111(2): 79-83



Chlordiazepoxide plus clidinium bromide (Librax(R)) was evaluated and compared with a placebo by means of a random sample, double-blind crossover technique in 42 patients presenting ordinary functional gastrointestinal disorders. * 73.9 percent excellent-to-good response to the active drug in patients receiving it before they received the placebo, compared with 44.5 percent in those who did not receive it until after the placebo period.* 58.9 percent excellent-to-good response to the active drug in patients who received it after the placebo period, as compared with 31.8 percent in those receiving the placebo last.* Overall clinical response 67.5 percent excellent-to-good with the active drug as compared with 37.5 percent with the placebo.* Excellent-to-good results in 12 follow-up patients receiving the known active drug.* Statistically significant symptomatic response in four of eight target symptoms. The tranquilizer-anticholinergic preparation used appeared to improve not only patient outlook and attitudes but to effectively relieve both the physiologic and psychic manifestations of common functional gastrointestinal disorders.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 042133648

Download citation: RISBibTeXText

PMID: 5394587


Related references

Anticholinergic-ataractic therapy in functional and organic gastrointestinal disorders; a controlled evaluation. Pennsylvania Medical Journal 62(2): 181-185, 1959

Evaluation of a new atropine-brand anticholinergic; clinical, gastric secretory and roentgenological effects in peptic ulcer and gastrointestinal functional disorders. American Journal of Gastroenterology 26(2): 170-198, 1956

Neurostimulation for abdominal pain-related functional gastrointestinal disorders in adolescents: a randomised, double-blind, sham-controlled trial. Lancet. Gastroenterology & Hepatology 2(10): 727-737, 2017

Double-blind study of a psychotropic-anticholinergic drug in gastric disorders. Medical Times 96(9): 933-938, 1968

Op-7 Therapeutic Effects Of Domperidone On Abdominal Pain-Predominant Functional Gastrointestinal Disorders: Randomized, Double-Blind, Placebo- Controlled Trial. Journal of Pediatric Gastroenterology and Nutrition 61(4): 511-512, 2015

Efficacy of a symbiotic preparation on functional intestinal disorders with altered bowel habit A double blind controlled study. Gastroenterology 120(5 Supplement 1): A 750-A 751, April, 2001

Tranquilizer anticholinergic therapy in functional gastrointestinal disorders. Applied Therapeutics 4: 828-9 Passim, 1962

Evaluation of a new benzodiazepine preparation, S-804, for the treatment of psychoneurotic and psychosomatic disorders by double-blind cross-over test. Saishin Igaku. Modern Medicine 25(5): 1128-1136, 1970

Management of functional bowel disorders: double-blind evaluation of Cantil and Cantate. Medical Times 96(10): 997-1003, 1968

The Frey syndrome: a review and double blind evaluation of the topical use of a new anticholinergic agent. Laryngoscope 88(11): 1796-1824, 1978

Clinical evaluation of an anticholinergic in the irritable colon syndrome; a double blind study of tricyclamol. American Journal of Gastroenterology 31(1): 47-52, 1959

A clinical evaluation of a new anticholinergic-antacid combination in the treatment of gastrointestinal disorders. American Journal of Gastroenterology 30(6): 618-623, 1958

Functional gastrointestinal disorders (FGID): progress in diagnosis and treatments. Topic I. Basic knowledge of functional gastrointestinal disorders (FGID); 3. Functional brain imaging studies on brain-gut interactions in functional gastrointestinal disorders. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 102(1): 17-24, 2013

Functional gastrointestinal disorders (FGID): progress in diagnosis and treatments. Topic I. Basic knowledge of functional gastrointestinal disorders (FGID); 6. Definition and overlaps of functional gastrointestinal disorders. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 102(1): 40-45, 2013

Functional gastrointestinal disorders (FGID): progress in diagnosis and treatments. Topic I. Basic knowledge of functional gastrointestinal disorders (FGID); 2. Psychosomatic aspects--role of stress and hormone in functional gastrointestinal disorder. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 102(1): 11-16, 2013